(Q41912305)

14 October 2017

title

Gastric inhibitory polypeptide (GIP) hypersecretion in obesity depends on meal size and is not related to hyperinsulinemia (English)

1 reference

14 October 2017

R Ebert

1

1 reference

14 October 2017

W Creutzfeldt

series ordinal

2

1 reference

14 October 2017

publication date

1 January 1989

1 reference

Acta diabetologica latina

14 October 2017

published in

1 reference

14 October 2017

volume

26

1 reference

14 October 2017

issue

1

1 reference

14 October 2017

page(s)

1-15

1 reference

The effect of endogenous gastric inhibitory polypeptide on glucose-induced insulin secretion in mild diabetes

14 October 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02581191

Downregulation of Insulin Receptors in Obese Man

21 January 2018

1 reference

12 December 2020

Pancreatic alpha- and beta-cell responses to GIP infusion in normal man

1 reference

12 December 2020

Gastric inhibitory polypeptide (GIP) stimulation by oral glucose in man

1 reference

12 December 2020

Gastric inhibitory polypeptide responses to nutrients in Caucasians and American Indians with obesity and noninsulin-dependent diabetes mellitus.

1 reference

12 December 2020

1 reference

12 December 2020

Radioimmunoassay of gastric inhibitory polypeptide and its release in morbid obesity and after jejuno-ileal bypass [proceedings]

1 reference

12 December 2020

Augmented gastric inhibitory polypeptide and insulin responses to a meal after an increase in carbohydrate (sucrose) intake

1 reference

12 December 2020

Disparity between glucose-dependent insulinotropic polypeptide and insulin responses in obese man.

1 reference

12 December 2020

Regulation of the gastric emptying of glucose

1 reference

12 December 2020

Identification and Actions of Gastric Inhibitory Polypeptide

1 reference

12 December 2020

The effect of increasing doses of ingested glucose on insulin and gastric inhibitory polypeptide (GIP) concentrations in man

1 reference

12 December 2020

The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera

1 reference

12 December 2020

The incretin concept today

1 reference

12 December 2020

Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity

1 reference

12 December 2020

Abnormalities of GIP in spontaneous syndromes of obesity and diabetes in mice

1 reference

12 December 2020

Insulin-dependent inhibition of hepatic glycogenolysis by gastric inhibitory polypeptide (GIP) in perfused rat liver

1 reference

12 December 2020

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group

1 reference

12 December 2020

Hypersecretion of Gastric Inhibitory Polypeptide Following Oral Glucose in Diabetes Mellitus

1 reference

12 December 2020

Gastric Inhibitory Polypeptide Enhanced Lipoprotein Lipase Activity in Cultured Preadipocytes

1 reference

12 December 2020

Reduced Hepatic Insulin Extraction in Obesity: Relationship with Plasma Insulin Levels

1 reference

12 December 2020

Effect of gastric inhibitory polypeptide on plasma levels of chylomicron triglycerides in dogs

1 reference

12 December 2020

Gastric inhibitory polypeptide and insulin response to increasing doses of oral glucose: dependency on glucose amount and volume of the test drink

1 reference

12 December 2020

Gastric inhibitory polypeptide (GIP) release and incretin effect after oral glucose in obesity and after jejunoileal bypass

1 reference

12 December 2020

Effects of atropine and gastric inhibitory polypeptide on hepatic glucose uptake and insulin extraction in conscious dogs

1 reference

12 December 2020

[On radio-immunologic determination of insulin in blood].

1 reference

12 December 2020

Release of gastric inhibitory polypeptide (GIP) by intraduodenal acidification in rats and humans and abolishment of the incretin effect of acid by GIP-antiserum in rats

1 reference

12 December 2020

Hyperinsulinemia of obesity is due to decreased clearance of insulin

1 reference

12 December 2020

Effects of diet on insulin and gastric inhibitory polypeptide levels in obese children

1 reference

12 December 2020

Radioimmunological determination of human C-peptide in serum

1 reference

12 December 2020

Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction

1 reference

12 December 2020

Gastric inhibitory polypeptide (GIP) and insulin in obesity: Increased response to stimulation and defective feedback control of serum levels

1 reference

12 December 2020

Gastric inhibitory polypeptide (GIP) in maturity-onset diabetes mellitus

1 reference

12 December 2020

Gastric inhibitory polypeptide (GIP) and insulin in obesity: II. Reversal of increased response to stimulation by starvation of food restriction

1 reference

12 December 2020

Gastric inhibitory polypeptide enhancement of the insulin effect on fatty acid incorporation into adipose tissue in the rat

1 reference

12 December 2020

Radioimmunoassay for Gastric Inhibitory Polypeptide

1 reference

12 December 2020

The Metabolism of Proinsulin and Insulin by the Liver

1 reference

12 December 2020

Effect of isocaloric exchange of dietary starch and sucrose in humans on the gastric inhibitory polypeptide response to a sucrose load

1 reference

12 December 2020

Effect of meal volume and energy density on the gastric emptying of carbohydrates

1 reference

12 December 2020

Gastric Inhibitory Polypeptide in Obesity and Diabetes Mellitus*

1 reference

12 December 2020

Decreased insulin removal contributes to hyperinsulinemia in obesity.

1 reference

12 December 2020

Gastric inhibitory polypeptide (GIP), gastrin and insulin: response to test meal in coeliac disease and after duodeno-pancreatectomy

1 reference

12 December 2020

Energy density of food, gastric emptying, and obesity

1 reference

12 December 2020

GIP and insulin responses to a test meal in healthy and obese subjects.

1 reference

12 December 2020

Gastric emptying and obesity

1 reference

12 December 2020

Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients

1 reference

12 December 2020

The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Effects of size, time of day and sequence of meal ingestion on carbohydrate tolerance in normal subjects

1 reference

12 December 2020

Failure of fasting to influence the GIP response to oral glucose in non-obese human subjects

1 reference

12 December 2020

Some Endocrine and Metabolic Aspects of Obesity

1 reference

12 December 2020

C-Peptide as a Measure of the Secretion and Hepatic Extraction of Insulin: Pitfalls and Limitations

1 reference

12 December 2020

Gastric inhibitory polypeptide (GIP). Intestinal distribution and stimulation by amino acids and medium-chain triglycerides

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02581191

1 reference

14 October 2017

1 reference